ERElena Rozhkova

Elena Rozhkova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Rozhkova has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Isolation of Mouse Hair Matrix Keratinocytes for Multi-omics Analysis

    by Guodong Chen, Elena Rozhkova, Andrey A. Sharov

    The isolation and molecular characterization of distinct cell populations from heterogeneous tissues are essential for investigating cell-type-specific functions and regulatory mechanisms, particularly within complex organs such as the skin. Here, we present a comprehensive workflow for isolating hair matrix cells from postnatal mouse skin using fluorescence-activated cell sorting (FACS) for gene expression and high-resolution chromatin profiling. The protocol begins with enzymatic dissociation of the skin to obtain a single-cell suspension, followed by immunolabeling with cell surface markers to enable precise FACS-based enrichment of the desired cell populations. A low-input CUT&Tag assay is then used to map histone posttranslational modifications, transcription factor binding sites, and DNA modifications. Importantly, this cell isolation strategy is compatible with a range of integrative multi-omics approaches including RNA sequencing (RNA-seq), assay for transposase-accessible chromatin using sequencing (ATAC-seq), whole-genome bisulfite sequencing (WGBS), and high-throughput chromosome conformation capture (Hi-C) using input material as low as ~100,000 cells per assay. Together, this methodology allows comprehensive, cell-type resolved analysis of the transcriptional and epigenetic landscapes in hair matrix keratinocytes in postnatal skin.


  • Inhibition of the CoREST Repressor Complex Promotes Wound Re-Epithelialization through the Regulation of Keratinocyte Migration

    by Maki Kida, Iqra Fatima, Elena Rozhkova, Marta Otero-Viñas, Muzhou Wu, Jay H. Kalin, Philip A. Cole, Vincent Falanga, Rhoda M. Alani, Andrey A. Sharov


  • Open Access

    Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma

    by Clare A. Rebbeck, Jian Xian, Susanne Bornelöv, Joseph Geradts, Amy Hobeika, Heather Geiger, Jose Franco Alvarez, Elena Rozhkova, Ashley Nicholls, Nicolas Robine, et al.

    Ductal carcinoma in situ (DCIS) is considered a non-invasive precursor to breast cancer, and although associated with an increased risk of developing invasive disease, many women with DCIS will never progress beyond their in situ diagnosis. The path from normal duct to invasive ductal carcinoma (IDC) is not well understood, and efforts to do so are hampered by the substantial heterogeneity that exists between patients, and even within patients. Here we show gene expression analysis from > 2,000 individually micro-dissected ductal lesions representing 145 patients. Combining all samples into one continuous trajectory we show there is a progressive loss in basal layer integrity heading towards IDC, coupled with two epithelial to mesenchymal transitions, one early and a second coinciding with the convergence of DCIS and IDC expression profiles. We identify early processes and potential biomarkers, including CAMK2N1 , MNX1 , ADCY5 , HOXC11 and ANKRD22 , whose reduced expression is associated with the progression of DCIS to invasive breast cancer.